SCHEMBL20784239

SCHEMBL20784239

CCOc1cc(-c2nnc(C3CC3)o2)ccc1C(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.48
MEN1 O00255 1/20 0.47
S1PR1 P21453 1/20 0.47
KMT2A Q03164 1/20 0.47
KDM4E B2RXH2 5/20 0.46
HPGD P15428 4/20 0.46
HSD17B10 Q99714 4/20 0.46
MAPK1 P28482 3/20 0.46
RAB9A P51151 2/20 0.46
LMNA P02545 1/20 0.46
TLR8 Q9NR97 8/20 0.45
TLR7 Q9NYK1 8/20 0.45
TLR9 Q9NR96 7/20 0.45
LRRK2 Q5S007 1/20 0.44
MAPT P10636 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
NPC1 O15118 1/20 0.43
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
ALOX15B O15296 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19329144 0.81 ALDH1A1 (0.46) ALDH1A1MEN1S1PR1KMT2AKDM4E
SCHEMBL23996994 0.81 TLR8 (0.50) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL19356293 0.81 S1PR1 (0.52) ALDH1A1MEN1S1PR1KMT2AKDM4E
SCHEMBL23571715 0.73 ALDH1A1 (0.59) ALDH1A1KDM4EMAPK1RAB9ATLR8
SCHEMBL29133063 0.72 ALDH1A1 (0.52) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL21939282 0.68 TLR8 (0.55) TLR8TLR7TLR9LRRK2MAPT
SCHEMBL19428321 0.68 CA1 (0.60) ALDH1A1KMT2AKDM4EHPGDHSD17B10
SCHEMBL19078690 0.68 KDM4E (0.50) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL19427972 0.67 POLB (0.62) ALDH1A1KMT2AKDM4EHPGDHSD17B10
SCHEMBL21958358 0.67 TLR8 (0.56) ALDH1A1MEN1KMT2AKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421743-B2 Tetrahydroisoquinolines as PRMT5 inhibitors CTXT PTY LTD (AU) 2019-09-24 US disclosed
US-20190071425-A1 TETRAHYDROISOQUINOLINES AS PRMT5 INHIBITORS CTXT PTY LTD (AU) 2019-03-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190071425-A1 TETRAHYDROISOQUINOLINES AS PRMT5 INHIBITORS PRMT5, PRMT1, PRMT3 ALDH1A1 4294/4885MEN1 162/4885S1PR1 2730/4885
US-10421743-B2 Tetrahydroisoquinolines as PRMT5 inhibitors PRMT5, PRMT1, PRMT3 ALDH1A1 4294/4885MEN1 162/4885S1PR1 2730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.